AgTech Corporate Governance
Pivot Bio Announces Additions to Senior Management
Nitrogen Innovation Leader Appoints Three Key Executives to Scale Corporate Strategy and Commercial Agronomy
In a major step to strengthen its corporate infrastructure and field execution pathways, Pivot Bio Announces Additions to Senior Management. Appointed on June 9, 2026, the new leadership trio includes Igor Gelemeev as Director of Corporate FP&A, Joe Olson as Commercial Agronomy Lead, and Andrew Weiler as Director of Growth. These senior hires bring decades of collective enterprise experience from top-tier firms including McKinsey & Company, Land O’Lakes, and WinField United. Reporting directly to the executive committee, they will spearhead Pivot Bio’s scaling operations, cross-functional business planning, and global commercial growth frameworks as the company expands its patented nitrogen-fixing microbial platforms across North America and South America.
MINNEAPOLIS, June 9, 2026 — Pivot Bio, one of the world’s leading innovative agtech companies, today announced the addition of three strategic hires to support the company’s next phase of growth. The new leaders bring expertise across finance, corporate development and commercial agronomy, further strengthening Pivot Bio’s ability to deliver innovative solutions that help farmers improve profitability and performance.
The leadership additions are:
- Igor Gelemeev, director, corporate FP&A
- Joe Olson, commercial agronomy lead
- Andrew Weiler, director of growth
“As Pivot Bio continues to grow, retaining and attracting leaders with strong financial, agronomic and operational expertise is critical to our next phase of impact. Igor, Joe and Andrew will each bring deep experience, strategic perspective and proven leadership that will strengthen our ability to scale innovation and create long-term value for farmers,” said Chris Abbott, CEO at Pivot Bio.
Gelemeev will report to Bob Houghton, chief financial officer; Olson will report to Chris Turner, chief commercial officer; and Weiler will report to Ryan Degnan, chief growth officer.
“Igor’s experience leading financial planning in high-growth environments makes him a strong addition to the team,” said Bob Houghton, chief financial officer at Pivot Bio. “He will play an important role in helping us drive operational excellence, improve visibility across the business and align investments with our long-term priorities.”
“Joe’s leadership is shaped by a unique ability to connect scientific research with real-world application, driving both agronomic performance and commercial success,” said Chris Turner, chief commercial officer at Pivot Bio. “He has consistently demonstrated a commitment to team development, technical excellence and advancing our products across diverse production environments.”
“Andrew brings a thoughtful, strategic approach to growth and corporate development, along with broad experience across agriculture, finance, and business transformation,” said Ryan Degnan, chief growth officer at Pivot Bio. “His ability to identify new opportunities, build strategic relationships and execute growth initiatives will help accelerate our expansion and extend our impact with farmers.”
About the Executives
Igor Gelemeev prior to Pivot Bio led Strategy FP&A at SPS Commerce, where he built the function from the ground up, supported M&A integrations, and delivered enhanced visibility to executive leadership. His career also includes leadership roles at Land O’Lakes and Polaris. Igor holds a Bachelor of Arts in finance and an MBA from the University of St. Thomas.
Joe Olson brings more than 15 years of agronomic experience spanning research, retail agronomy, and commercial leadership. Since joining Pivot Bio in 2022, he has progressed from commercial agronomist to regional commercial agronomy lead. Before Pivot Bio, Olson built a well-rounded foundation at WinField United leading agronomic research programs and executing field initiatives through the national Answer Plot system. He holds a Bachelor’s degree from Dakota State University.
Andrew Weiler is an agribusiness leader with experience spanning corporate development, commercial strategy, and operations across the Americas and Africa. Prior to Pivot Bio, Weiler was an engagement manager at McKinsey & Company advising agriculture clients on commercial transformations. He also held leadership positions with The Perennial Foods Group in Ethiopia and co-founded Kib Herbal Tea. He graduated cum laude with a BA in Economics from the University of Notre Dame.
About Pivot Bio
Pivot Bio delivers patented crop nutrition technologies that harness the power of nature to help farmers reliably and productively grow crops in the face of increasing volatility. Currently available in North America and soon in Brazil, the company’s products represent a breakthrough innovation and one of the agriculture industry’s most promising solutions to optimize crop nutrition performance and reduce synthetic resource reliance.
Strategic Market Context
The expansion of management structures at premier agtech innovators reflects a broader institutional evolution as pure-play biological platforms transition into mainstream commercial entities. As input volatility and regulatory shifts drive a multi-billion-dollar market expansion for alternatives, leading corporations are recruiting institutional talent from consulting, corporate finance, and enterprise research to optimize execution. This scaling framework runs parallel to major structural updates across the bio-input landscape, such as Rovensa Next securing exclusive U.S. distribution rights for Novonesis plant health portfolios to tap into a $5.5 billion dynamic market, and Switch Bioworks advancing genetic-switch microbial inputs into Midwest field trials under USDA and EPA clearances to solve the metabolic energy limitations of living root fertilizers.
Pivot Bio, Inc. – Global Corporate Headquarters
Minneapolis, Minnesota | Executive Appointments & Corporate Registry | June 2026 | pivotbio.com
Leave a Reply